Categories: HealthcareNews

Agile Therapeutics to Report Third Quarter 2022 Financial Results and Provide Business Update on Monday, November 7, 2022

FacebookFacebookTwitterTwitterEmailEmailLinkedInLinkedInWhatsAppWhatsAppMessengerMessengerFlipboardFlipboardGmailGmailTelegramTelegramShareShare

Live Conference Call and Webcast at 4:30 p.m. ET

PRINCETON, N.J., Oct. 26, 2022 (GLOBE NEWSWIRE) — Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare company, today announced it will report third quarter 2022 financial results after the market close on Monday, November 7, 2022. Following the release, the Company will host a live conference call and webcast at 4:30 p.m. ET to discuss the Company’s financial results and provide a business update.

Event Agile Therapeutics Third Quarter 2022 Financial Results Conference Call
Date Monday, November 7, 2022
Time 4:30 p.m. ET / 1:30 p.m. PT

A live webcast of the conference call may be accessed via the Investor Relations portion of the Agile Therapeutics website at https://ir.agiletherapeutics.com/events-and-presentations. To participate in the live conference call via telephone, please register here. Upon registering, a dial-in number and unique PIN will be provided to join the conference call.

About Agile Therapeutics, Inc.
Agile Therapeutics is a women’s healthcare company dedicated to fulfilling the unmet health needs of today’s women. Our product and product candidates are designed to provide women with contraceptive options that offer freedom from taking a daily pill, without committing to a longer-acting method. Our initial product, Twirla®, (levonorgestrel and ethinyl estradiol), a transdermal system, is a non-daily prescription contraceptive. Twirla is based on our proprietary transdermal patch technology, called Skinfusion®, which is designed to allow drug delivery through the skin. For more information, please visit the company website at www.agiletherapeutics.com. The Company may occasionally disseminate material, nonpublic information on the Company’s website, Twitter account (@agilether), and LinkedIn account. 

CONTACT: Contact:
Matt Riley
Head of Investor Relations & Corporate Communications
mriley@agiletherapeutics.com

Staff

Recent Posts

SURGLASSES Launches the World’s First AI Anatomy Table

Asclepius AI Table sets a new benchmark for intelligent, hands-on medical learning. TAIPEI, June 19,…

8 hours ago

Semler Scientific® Appoints Joe Burnett as Director of Bitcoin Strategy; Targets Owning at Least 10,000 Bitcoins by Year-End 2025 and 105,000 by Year-End 2027

CAMPBELL, Calif., June 19, 2025 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a publicly traded…

14 hours ago

The Department of Health – Abu Dhabi and Abbot Unite to Manufacture Pharmaceuticals Locally in Abu Dhabi

Reinforcing Abu Dhabi's position as a global life science hub ABU DHABI, UAE, June 19,…

14 hours ago

ACI Infotech Accelerates Growth with Exclusive Salesforce-Agentforce Partnership and Bold Vision for the Future

SOMERSET, N.J., June 19, 2025 /PRNewswire/ -- ACI Infotech, a tech consulting powerhouse with deep AI,…

14 hours ago

Bridge joins the Elation Health Partner Hub to Elevate Patient Engagement for Elation EHR Users

The award-winning BridgeInteract patient engagement platform gives Elation customers a turnkey suite of self-service tools…

14 hours ago